Reuters logo
BRIEF-Enanta Pharma Says Abbvie’s Maviret ‍is Now Commercially Available In Japan​
November 30, 2017 / 12:39 PM / 15 days ago

BRIEF-Enanta Pharma Says Abbvie’s Maviret ‍is Now Commercially Available In Japan​

Nov 30 (Reuters) - Enanta Pharmaceuticals Inc:

* ENANTA PHARMACEUTICALS - ABBVIE‘S MAVIRET HAS BEEN APPROVED FOR REIMBURSEMENT BY MINISTRY OF HEALTH, LABOUR AND WELFARE

* ENANTA PHARMACEUTICALS - ABBVIE’S MAVIRET ‍IS NOW COMMERCIALLY AVAILABLE IN JAPAN​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below